We identified upregulated TSGs related to the inhibition of colon cancer progression after CUR treatment via comprehensive bioinformatics analysis and demonstrated that CUR inhibited the proliferation and migration of colon cancer cell lines by reactivating TSGs such as ARHGEF12 and APAF1 via cancer pathways. Here, ARHGEF12 is linked to malignant colon neoplasm.